MedTrace Logo

Sources of COmplement in Meningococcal and Pertussis Serum Bactericidal Antibody Assays

NCT04023929 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2021-01-12

No results posted yet for this study

Summary

This study is designed to allow cord blood sample collection from the cords of babies born in three gestational age windows: ≥37 gestational weeks, 32-36+6 gestational weeks and less than 32 gestational weeks to investigate whether the result obtained using a standard hSBA assay is comparable to that achieved using complement from a gestation matched population for meningococcal B and pertussis.

Conditions

  • Pertussis
  • Meningococcal Disease
  • Prematurity

Interventions

PROCEDURE

Cord blood sampling

A cord blood sample will be obtained after the baby has been delivered and the cord has been clamped and cut.

Sponsors & Collaborators

  • St George's, University of London

    lead OTHER

Principal Investigators

  • Anna Calvert, MBChB · St George's, Univeristy of London

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-28
Primary Completion
2021-09-21
Completion
2021-09-21

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04023929 on ClinicalTrials.gov